🇺🇸 FDA
Pipeline program

Dovato 50 mg/300 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets

222638

Phase 2 small_molecule active

Quick answer

Dovato 50 mg/300 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets for HIV Infections is a Phase 2 program (small_molecule) at ViiV Healthcare BV with 1 ClinicalTrials.gov record(s).

Program details

Company
ViiV Healthcare BV
Indication
HIV Infections
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials